Patrick Anquetil Speaks at LSI's 2023 Emerging MedTech Summit
Watch Patrick Anquetil, CEO of Portal Instruments, take the stage at…
Portal Featured in Drug Development and Delivery Special Feature
Portal Instruments: PFS Addresses Variety of Injection Challenges…
Portal Instruments Welcomes William (Bill) Rich to the Board of Directors
Portal Instruments Welcomes William (Bill) Rich to the Board of…
Portal Instruments appoints Dr. Veena Rao, PhD, as Chief Business Officer
December 5th, 2022 Cambridge, MA—Portal Instruments is pleased to…
Needle-Free: A Nurse's Perspective
According to the CDC, nurses are affected by needle stick injuries…
A Difficult Needle to Thread
This blog was written by Logan Merrill for Portal Instruments. All opinions and…
Gerresheimer and Portal enter strategic partnership to treat chronically ill patients with innovative needle-free drug-delivery solution
DUESSELDORF, Germany and CAMBRIDGE, Mass., May 9, 2022 —…
Investigation into the Feasibility of a 2 mL Needle-Free Injector
The current paradigm of injectable drug delivery has stagnated since…
Raising Awareness On The Challenges Of Injections: "My First Injection"
Twelve years ago Jody started getting unexplained pain, swelling and…
